Laura Walker, PhD

Head of Infectious Disease Biotherapeutics Engineering and Discovery at Moderna

Speaker

Laura Walker, Ph.D., is the head of infectious disease biotherapeutic discovery and engineering at Moderna. Upon completion of her doctoral training, she served as Sr. Director of Antibody Sciences at Adimab, where she and her team studied human antibody responses to a wide variety of emerging viral pathogens, including Ebola, Zika, yellow fever, and SARS-CoV-2. In 2020, Dr. Walker became a co-founder and CSO of Adagio Therapeutics, where she oversaw a broad portfolio of research in the area of viral immunology, including the discovery and development of monoclonal antibodies to influenza and SARS-CoV-2. Laura earned her Ph.D. in Immunology and Microbiology at The Scripps Research Institute in 2012 under the mentorship of Dennis R. Burton.